Home/Filings/4/0001094891-19-000093
4//SEC Filing

Aklog Lishan 4

Accession 0001094891-19-000093

CIK 0001624326other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:18 PM ET

Size

9.8 KB

Accession

0001094891-19-000093

Insider Transaction Report

Form 4
Period: 2019-03-15
Aklog Lishan
DirectorChairman and CEO
Transactions
  • Award

    Common Stock

    2019-03-15+200,000818,413 total
Holdings
  • Common Stock

    (indirect: By son)
    2,280
  • Common Stock

    (indirect: By LLC)
    4,456,570
  • Common Stock

    (indirect: By LLC)
    20,000
  • Common Stock

    (indirect: By daughter)
    2,303
Transactions
  • Award

    Common Stock

    2019-03-15+200,000818,413 total
Holdings
  • Common Stock

    (indirect: By daughter)
    2,303
  • Common Stock

    (indirect: By son)
    2,280
  • Common Stock

    (indirect: By LLC)
    20,000
  • Common Stock

    (indirect: By LLC)
    4,456,570
Footnotes (3)
  • [F1]The issuer granted 200,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
  • [F2]Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
  • [F3]Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein.

Issuer

PAVmed Inc.

CIK 0001624326

Entity typeother

Related Parties

1
  • filerCIK 0001665074

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:18 PM ET
Size
9.8 KB